← All signals
Signal

Merck KGaA and M Ventures Set Deadline for Reproductive Health Accelerator Applications

Category
· Ecosystem Shift · Global
Date
August 26, 2026
Source
OVUM

Summary

The W Accelerate program, a joint initiative by Merck KGaA and M Ventures, closes applications on September 2. The program offers startups and spinouts in the maternal and reproductive health sectors direct access to corporate decision-makers and venture capital investment.

Positions inside Maternal & Newborn are shifting, and the useful question is which neighbouring companies are affected. Watch for follow-on moves from the investors, incumbents, and new entrants named here.

OVUM interpretation layer

The editorial read on this signal — pattern, market-structure implications, and what to watch next.

Sources

The OVUM Intelligence Brief

Keep reading past this page

The week's funding, launches, and studies in women's health, in plain English.

Weekly. No spam. Unsubscribe anytime.